ECO Animal Health Group (LON:EAH) Given “Buy” Rating at Shore Capital

Shore Capital reaffirmed their buy rating on shares of ECO Animal Health Group (LON:EAH) in a research note published on Monday morning,Digital Look reports.

ECO Animal Health Group Price Performance

Shares of LON EAH opened at GBX 58.04 ($0.75) on Monday. The stock has a market capitalization of £39.33 million, a price-to-earnings ratio of 37.52 and a beta of -0.05. ECO Animal Health Group has a 12 month low of GBX 56.60 ($0.73) and a 12 month high of GBX 135 ($1.74). The firm’s 50 day simple moving average is GBX 63.71 and its 200-day simple moving average is GBX 77.09. The company has a debt-to-equity ratio of 4.81, a current ratio of 2.96 and a quick ratio of 2.14.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.